Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Jul 14, 2023

BUY
$214.27 - $253.37 $1.84 Million - $2.17 Million
8,580 New
8,580 $1.91 Million
Q3 2022

Oct 25, 2022

SELL
$224.46 - $253.15 $1.78 Million - $2.01 Million
-7,939 Closed
0 $0
Q2 2022

Aug 24, 2022

BUY
$230.71 - $256.74 $14,765 - $16,431
64 Added 0.81%
7,939 $1.93 Million
Q1 2022

May 06, 2022

BUY
$219.27 - $242.57 $22,146 - $24,499
101 Added 1.3%
7,875 $1.9 Million
Q4 2021

Feb 08, 2022

BUY
$198.88 - $227.6 $1.55 Million - $1.77 Million
7,774 New
7,774 $1.75 Million
Q3 2021

Nov 10, 2021

SELL
$212.27 - $248.7 $1.47 Million - $1.72 Million
-6,930 Closed
0 $0
Q1 2021

Apr 26, 2021

BUY
$221.91 - $258.6 $21,081 - $24,567
95 Added 1.39%
6,930 $1.72 Million
Q3 2020

Oct 23, 2020

SELL
$234.65 - $260.95 $12,436 - $13,830
-53 Reduced 0.77%
6,835 $1.74 Million
Q2 2020

Jul 21, 2020

BUY
$197.81 - $242.74 $9,099 - $11,166
46 Added 0.67%
6,888 $1.63 Million
Q1 2020

Apr 21, 2020

BUY
$182.24 - $241.7 $330,583 - $438,443
1,814 Added 36.08%
6,842 $1.39 Million
Q4 2019

Feb 07, 2020

BUY
$189.21 - $243.2 $140,015 - $179,968
740 Added 17.26%
5,028 $1.21 Million
Q3 2019

Nov 07, 2019

BUY
$174.11 - $208.62 $80,438 - $96,382
462 Added 12.08%
4,288 $830,000
Q2 2019

Jul 29, 2019

BUY
$166.7 - $195.41 $25,171 - $29,506
151 Added 4.11%
3,826 $705,000
Q1 2019

May 07, 2019

BUY
$180.87 - $203.88 $60,229 - $67,892
333 Added 9.96%
3,675 $698,000
Q4 2018

Jan 31, 2019

BUY
$178.4 - $208.25 $596,212 - $695,971
3,342 New
3,342 $651,000

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $150B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Cordatus Wealth Management LLC Portfolio

Follow Cordatus Wealth Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cordatus Wealth Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cordatus Wealth Management LLC with notifications on news.